Last reviewed · How we verify

Nucleo CMP Forte — Competitive Intelligence Brief

Nucleo CMP Forte (Nucleo CMP Forte) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Nucleotide supplement. Area: Immunology; Nutritional support.

phase 3 Nucleotide supplement Nucleotide metabolism pathways; cellular energy (ATP) production Immunology; Nutritional support Small molecule Live · refreshed every 30 min

Target snapshot

Nucleo CMP Forte (Nucleo CMP Forte) — Sherief Abd-Elsalam. Nucleo CMP Forte is a nucleotide-based supplement designed to support cellular energy metabolism and immune function through provision of cytidine monophosphate and related nucleotide precursors.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Nucleo CMP Forte TARGET Nucleo CMP Forte Sherief Abd-Elsalam phase 3 Nucleotide supplement Nucleotide metabolism pathways; cellular energy (ATP) production

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Nucleotide supplement class)

  1. Sherief Abd-Elsalam · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Nucleo CMP Forte — Competitive Intelligence Brief. https://druglandscape.com/ci/nucleo-cmp-forte. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: